About
Small Molecules, Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
596
By Phase
PHASE2: 2PHASE1/PHASE2: 2
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04522830Lead Sponsor
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
PHASE2Completed
28 participants
Started: Jul 30, 2020 · Completed: Feb 28, 2021
NCT01902303Lead Sponsor
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
PHASE2Completed
303 participants
Started: Jul 31, 2013 · Completed: Feb 28, 2015
NCT01340066Lead Sponsor
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
PHASE1/PHASE2Completed
94 participants
Started: Apr 30, 2011 · Completed: May 31, 2012
NCT01308424Lead Sponsor
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
PHASE1/PHASE2Completed
171 participants
Started: Jan 31, 2011 · Completed: Nov 30, 2012
Locations (1)
Headquarters
Providence, RI, United States
Map
Loading map...